post-marketing observational study
Showing 26 - 50 of >10,000
Vericiguat in Korean People With Chronic Heart Failure With
Not yet recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- Vericiguat (Verquvo, BAY1021189)
-
Multiple Locations, Korea, Republic ofMany Locations
Nov 20, 2023
Evaluate Immunogenicity of AryoSeven
Completed
- Hemophilia A With Inhibitor
- +3 more
-
Tehran, Iran, Islamic Republic of
- +1 more
Feb 14, 2022
Using Commercially Approved Biosense Webster Medical Devices for
Recruiting
- Cardiac Arrhythmias
- BWI Medical Device
-
Linz, Austria
- +13 more
Jan 23, 2023
Naloxegol US PMR CV Safety.
Active, not recruiting
- Opioid Induced Constipation
-
Wilmington, Delaware
- +1 more
Sep 14, 2021
(Use-results Surveillance) With Esperoct®
Enrolling by invitation
- Haemophilia A
- Turoctocog alfa pegol
-
Fukuoka, Japan
- +14 more
Nov 8, 2022
Disease Activity and Adverse Events in Adolescent and Adult
Recruiting
- Crohn's Disease
-
Toyota-shi, Aichi, Japan
- +1 more
Aug 29, 2023
Learn About Study Medicine Zavicefta After it is Released Into
Not yet recruiting
- Complicated Intra-abdominal Infection
- +2 more
- (no location specified)
Feb 16, 2023
Fibrocystic Breast Disease Trial in Almaty (Vitex Agnus Castus Extract)
Completed
- Fibrocystic Breast Disease
- Vitex Agnus Castus Extract
-
Almaty, Almaty Region, KazakhstanKazakh Institute of Oncology and Radiology
Jan 29, 2023
Disease Activity and Adverse Events of Rinvoq in Adult Moderate
Recruiting
- Ulcerative Colitis
-
Kurume-shi, Fukuoka, Japan
- +4 more
Mar 17, 2023
Pancreatic Tumor, Digestive System Tumor, Tumors by Site Trial
Not yet recruiting
- Pancreatic Neoplasm
- +7 more
- (no location specified)
Apr 19, 2022
Called VERI-China, to Learn More About How Well Vericiguat Works
Not yet recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- Vericiguat (Verquvo, BAY1021189)
- Standard of Care (SoC)
-
Multiple Locations, Many Locations, ChinaChinese Registries
Feb 6, 2023
Venetoclax Treatment in Chronic Lymphocytic Leukemia Routine
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
Be'er Sheva, HaDarom, Israel
- +12 more
Sep 9, 2022
Indocyanine Green for Breast Cancer HavingSentinel Lymph Node
Recruiting
- Breast Cancer
- Sentinel lymph node identification
- +3 more
-
Annecy, Epagny Metz-Tessy, Haute-Savoie, France
- +5 more
Sep 5, 2023
A 24-week rPMS Study in Real-world Setting for Enerzair
Recruiting
- Asthma
- Enerzair 150/50/80 μg
- Enerzair 150/50/160 μg
-
Suncheon, Jeollanam-do, Korea, Republic ofNovartis Investigative Site
Jun 13, 2022
The Medacta International GMK Sphere Cementless Post-Marketing
Recruiting
- Arthritis
- +4 more
- GMK Sphere cementless Knee Replacement
-
Bourgoin-Jallieu, France
- +4 more
Aug 6, 2021
Assess the Safety of Fedratinib in Korean Myelofibrosis
Recruiting
- Primary Myelofibrosis
- +2 more
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Assess Safety of Ozanimod in Moderate to Severe Active UC in
Not yet recruiting
- Ulcerative Colitis
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia
Not yet recruiting
- Myelodysplastic Syndrome
- Beta Thalassemia
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- Oral azacitidine
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
Recruiting
- SARS-CoV-2
- SPIKEVAX
-
New York, New YorkAetion, Inc
Nov 8, 2023
Cataract Trial in Buenos Aires
Completed
- Cataract
-
Buenos Aires, ArgentinaDr. Nano Eye Clinic
Oct 10, 2023
BIOFLOW-china Post-marketing Study (BIOTRONIK)
Not yet recruiting
- In-Stent Stenosis (Restenosis) of Coronary Artery Stent
- Native Coronary Artery Stenosis
- BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
-
Harbin, Heilongjiang, ChinaThe Fourth Affiliated Hospital of Harbin Medical University
Dec 26, 2022
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Completed
- Thoracic Aortic Aneurysm
- +2 more
- Conformable GORE® TAG® Thoracic Endoprosthesis
- (no location specified)
Jan 11, 2023